AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
CELL-LINE DESIGNATION CHANGE - MULTIDRUG-RESISTANT CELL-LINE IN THE NCI ANTICANCER SCREEN
Authors: SCUDIERO DA MONKS A SAUSVILLE EA
Citation: Da. Scudiero et al., CELL-LINE DESIGNATION CHANGE - MULTIDRUG-RESISTANT CELL-LINE IN THE NCI ANTICANCER SCREEN, Journal of the National Cancer Institute, 90(11), 1998, pp. 862-862
PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS
Authors: CONLEY BA EGORIN MJ TAIT N ROSEN DM SAUSVILLE EA DOVER G FRAM RJ VANECHO DA
Citation: Ba. Conley et al., PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(3), 1998, pp. 629-634
PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS
Authors: CONLEY BA EGORIN MJ TAIT N ROSEN DM SAUSVILLE EA DOVER G FRAM RJ VANECHO DA
Citation: Ba. Conley et al., PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(3), 1998, pp. 629-634
CYCLIN-DEPENDENT KINASES - TARGETS FOR NOVEL THERAPEUTIC APPROACHES
Authors: SAUSVILLE EA HEADLEE D STINSON SF LUSH RM FIGG WD ARBUCK SG SENDEROWICZ AM
Citation: Ea. Sausville et al., CYCLIN-DEPENDENT KINASES - TARGETS FOR NOVEL THERAPEUTIC APPROACHES, Annals of oncology, 9, 1998, pp. 50-50
CELL-BASED SCREENING AND PHARMACOLOGICAL STRATEGIES FOR THE SELECTIONOF NEW ANTICANCER AGENTS - A COLLABORATION BETWEEN THE NATIONAL-CANCER-INSTITUTE (NCI), CANCER-RESEARCH CAMPAIGN (CRC) AND EORTC
Authors: HENDRIKS HR BURTLES S RADTKE S SCHULTZ RJ DOUBLE JA SAUSVILLE EA NEWELL DR
Citation: Hr. Hendriks et al., CELL-BASED SCREENING AND PHARMACOLOGICAL STRATEGIES FOR THE SELECTIONOF NEW ANTICANCER AGENTS - A COLLABORATION BETWEEN THE NATIONAL-CANCER-INSTITUTE (NCI), CANCER-RESEARCH CAMPAIGN (CRC) AND EORTC, Annals of oncology, 9, 1998, pp. 155-155
PRECLINICAL STUDIES ON 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLE
Authors: CHUA MS SAUSVILLE EA HUTCHINSON I BRADSHAW TD STEVENS MFG
Citation: Ms. Chua et al., PRECLINICAL STUDIES ON 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLE, Annals of oncology, 9, 1998, pp. 185-185
PHASE-I TRIAL OF INFUSIONAL UCN-01, A NOVEL PROTEIN-KINASE INHIBITOR,IN PATIENTS WITH REFRACTORY NEOPLASMS
Authors: SENDEROWICZ AM HEADLEE D LUSH R ARBUCK S BAUER K FIGG WD MURGO A INOUE K KOBASHI S KUWABARA T SAUSVILLE EA
Citation: Am. Senderowicz et al., PHASE-I TRIAL OF INFUSIONAL UCN-01, A NOVEL PROTEIN-KINASE INHIBITOR,IN PATIENTS WITH REFRACTORY NEOPLASMS, Annals of oncology, 9, 1998, pp. 426-426
ANTITUMOR-ACTIVITY OF 17-ALLYLAMINOGELDANAMYCIN (NSC-330507) IN MELANOMA XENOGRAFTS IS ASSOCIATED WITH DECLINE IN HSP90 PROTEIN EXPRESSION
Authors: BURGER AM FIEBIG HH NEWMAN DJ CAMALIER RF SAUSVILLE EA
Citation: Am. Burger et al., ANTITUMOR-ACTIVITY OF 17-ALLYLAMINOGELDANAMYCIN (NSC-330507) IN MELANOMA XENOGRAFTS IS ASSOCIATED WITH DECLINE IN HSP90 PROTEIN EXPRESSION, Annals of oncology, 9, 1998, pp. 504-504
PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS
Authors: SENDEROWICZ AM HEADLEE D STINSON SF LUSH RM KALIL N VILLALBA L HILL K STEINBERG SM FIGG WD TOMPKINS A ARBUCK SG SAUSVILLE EA
Citation: Am. Senderowicz et al., PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS, Journal of clinical oncology, 16(9), 1998, pp. 2986-2999
CLINICAL-PHARMACOLOGY OF UCN-01 - INITIAL OBSERVATIONS AND COMPARISONTO PRECLINICAL MODELS
Authors: SAUSVILLE EA LUSH RD HEADLEE D SMITH AC FIGG WD ARBUCK SG SENDEROWICZ AM FUSE E TANII H KUWABARA T KOBAYASHI S
Citation: Ea. Sausville et al., CLINICAL-PHARMACOLOGY OF UCN-01 - INITIAL OBSERVATIONS AND COMPARISONTO PRECLINICAL MODELS, Cancer chemotherapy and pharmacology, 42, 1998, pp. 54-59
JASPLAKINOLIDE - INTERACTION WITH RADIATION AND HYPERTHERMIA IN HUMANPROSTATE CARCINOMA AND LEWIS-LUNG-CARCINOMA
Authors: TAKEUCHI H ARA G SAUSVILLE EA TEICHER B
Citation: H. Takeuchi et al., JASPLAKINOLIDE - INTERACTION WITH RADIATION AND HYPERTHERMIA IN HUMANPROSTATE CARCINOMA AND LEWIS-LUNG-CARCINOMA, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 491-496
PRECLINICAL EVALUATION OF 9-CHLORO-2-METHYLELLIPTICINIUM ACETATE ALONE AND IN COMBINATION WITH CONVENTIONAL ANTICANCER DRUGS FOR THE TREATMENT OF HUMAN BRAIN-TUMOR XENOGRAFTS
Authors: ARGUELLO F ALEXANDER MA GREENE JF STINSON SF JORDEN JL SMITH EM KALAVAR NT ALVORD WG KLABANSKY RL SAUSVILLE EA
Citation: F. Arguello et al., PRECLINICAL EVALUATION OF 9-CHLORO-2-METHYLELLIPTICINIUM ACETATE ALONE AND IN COMBINATION WITH CONVENTIONAL ANTICANCER DRUGS FOR THE TREATMENT OF HUMAN BRAIN-TUMOR XENOGRAFTS, Journal of cancer research and clinical oncology, 124(1), 1998, pp. 19-26
OLD AND NEW THERAPIES IN CHRONIC LYMPHOCYTIC-LEUKEMIA - NOW IS THE TIME FOR A REASSESSMENT OF THERAPEUTIC GOALS
Authors: BYRD JC RAI KR SAUSVILLE EA GREVER MR
Citation: Jc. Byrd et al., OLD AND NEW THERAPIES IN CHRONIC LYMPHOCYTIC-LEUKEMIA - NOW IS THE TIME FOR A REASSESSMENT OF THERAPEUTIC GOALS, Seminars in oncology, 25(1), 1998, pp. 65-74
METABOLISM OF THE ANTICANCER DRUG FLAVOPIRIDOL, A NEW INHIBITOR OF CYCLIN-DEPENDENT KINASES, IN RAT-LIVER
Authors: JAGER W ZEMBSCH B WOLSCHANN P PITTENAUER E SENDEROWICZ AM SAUSVILLE EA SEDLACEK HH GRAF J THALHAMMER T
Citation: W. Jager et al., METABOLISM OF THE ANTICANCER DRUG FLAVOPIRIDOL, A NEW INHIBITOR OF CYCLIN-DEPENDENT KINASES, IN RAT-LIVER, Life sciences, 62(20), 1998, pp. 1861-1873
FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, SUPPRESSES THE GROWTH OF HEAD AND NECK SQUAMOUS-CELL CARCINOMAS BY INDUCING APOPTOSIS
Authors: PATEL V SENDEROWICZ AM PINTO D IGISHI T RAFFELD M QUINTANILLAMARTINEZ L ENSLEY JF SAUSVILLE EA GUTKIND JS
Citation: V. Patel et al., FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, SUPPRESSES THE GROWTH OF HEAD AND NECK SQUAMOUS-CELL CARCINOMAS BY INDUCING APOPTOSIS, The Journal of clinical investigation, 102(9), 1998, pp. 1674-1681
IN-VITRO GLUCURONIDATION OF FLAVOPIRIDOL (NSC649890) (FLAVO) BY HUMANLIVER-MICROSOMES
Authors: RAMIREZ J IYER L LUSH RM MORTELL M FEUER JA FIGG WD SAUSVILLE EA RATAIN MJ
Citation: J. Ramirez et al., IN-VITRO GLUCURONIDATION OF FLAVOPIRIDOL (NSC649890) (FLAVO) BY HUMANLIVER-MICROSOMES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 50-50
UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN
Authors: FUSE E TANII H KURATA N KOBAYASHI H SHIMADA Y TAMURA T SASAKI Y TANIGAWARA Y LUSH RD HEADLEE D FIGG WD ARBUCK SG SENDEROWICZ AM SAUSVILLE EA AKINAGA S KUWAHARA A KOBASASHI S
Citation: E. Fuse et al., UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN, Cancer research, 58(15), 1998, pp. 3248-3253
FLAVOPIRIDOL INDUCES APOPTOSIS OF NORMAL LYMPHOID-CELLS, CAUSES IMMUNOSUPPRESSION, AND HAS POTENT ANTITUMOR-ACTIVITY IN-VIVO AGAINST HUMAN LEUKEMIA AND LYMPHOMA XENOGRAFTS
Authors: ARGUELLO F ALEXANDER M STERRY JA TUDOR G SMITH EM KALAVAR NT GREENE JF KOSS W MORGAN CD STINSON SF SIFORD TJ ALVORD WG KLABANSKY RL SAUSVILLE EA
Citation: F. Arguello et al., FLAVOPIRIDOL INDUCES APOPTOSIS OF NORMAL LYMPHOID-CELLS, CAUSES IMMUNOSUPPRESSION, AND HAS POTENT ANTITUMOR-ACTIVITY IN-VIVO AGAINST HUMAN LEUKEMIA AND LYMPHOMA XENOGRAFTS, Blood, 91(7), 1998, pp. 2482-2490
EARLY INDUCTION OF APOPTOSIS IN HEMATOPOIETIC-CELL LINES AFTER EXPOSURE TO FLAVOPIRIDOL
Authors: PARKER BW KAUR G NIEVESNEIRA W TAIMI M KOHLHAGEN G SHIMIZU T LOSIEWICZ MD POMMIER Y SAUSVILLE EA SENDEROWICZ AM
Citation: Bw. Parker et al., EARLY INDUCTION OF APOPTOSIS IN HEMATOPOIETIC-CELL LINES AFTER EXPOSURE TO FLAVOPIRIDOL, Blood, 91(2), 1998, pp. 458-465
EXPRESSION AND LOCATION OF PRO-APOPTOTIC BCL-2 FAMILY PROTEIN BAD IN NORMAL HUMAN TISSUES AND TUMOR-CELL LINES
Authors: KITADA S KRAJEWSKA M ZHANG X SCUDIERO D ZAPATA JM WANG HG SHABAIK A TUDOR G KRAJEWSKI S MYERS TG JOHNSON GS SAUSVILLE EA REED JC
Citation: S. Kitada et al., EXPRESSION AND LOCATION OF PRO-APOPTOTIC BCL-2 FAMILY PROTEIN BAD IN NORMAL HUMAN TISSUES AND TUMOR-CELL LINES, The American journal of pathology, 152(1), 1998, pp. 51-61
IDENTIFICATION OF COMPOUNDS WITH PREFERENTIAL INHIBITORY ACTIVITY AGAINST LOW-NM23-EXPRESSING HUMAN BREAST-CARCINOMA AND MELANOMA CELL-LINES
Authors: FREIJE JMP LAWRENCE JA HOLLINGSHEAD MG DELAROSA A NARAYANAN V GREVER M SAUSVILLE EA PAULL K STEEG PS
Citation: Jmp. Freije et al., IDENTIFICATION OF COMPOUNDS WITH PREFERENTIAL INHIBITORY ACTIVITY AGAINST LOW-NM23-EXPRESSING HUMAN BREAST-CARCINOMA AND MELANOMA CELL-LINES, Nature medicine, 3(4), 1997, pp. 395-401
AZODICARBONAMIDE INHIBITS HIV-1 REPLICATION BY TARGETING THE NUCLEOCAPSID PROTEIN
Authors: RICE WG TURPIN JA HUANG MJ CLANTON D BUCKHEIT RW COVELL DG WALLQVIST A MCDONNELL NB DEGUZMAN RN SUMMERS MF ZALKOW L BADER JP HAUGWITZ RD SAUSVILLE EA
Citation: Wg. Rice et al., AZODICARBONAMIDE INHIBITS HIV-1 REPLICATION BY TARGETING THE NUCLEOCAPSID PROTEIN, Nature medicine, 3(3), 1997, pp. 341-345
ANTIPROLIFERATIVE ACTIVITY IN-VITRO AND IN-VIVO OF THE SPICAMYCIN ANALOG KRN5500 WITH ALTERED GLYCOPROTEIN EXPRESSION IN-VITRO
Authors: BURGER AM KAUR G HOLLINGSHEAD M FISCHER RT NAGASHIMA K MALSPEIS L DUNCAN KLK SAUSVILLE EA
Citation: Am. Burger et al., ANTIPROLIFERATIVE ACTIVITY IN-VITRO AND IN-VIVO OF THE SPICAMYCIN ANALOG KRN5500 WITH ALTERED GLYCOPROTEIN EXPRESSION IN-VITRO, Clinical cancer research, 3(3), 1997, pp. 455-463
FLAVOPIRIDOL (L86-8275) - SELECTIVE ANTITUMOR-ACTIVITY IN-VITRO AND ACTIVITY IN-VIVO FOR PROSTATE CARCINOMA-CELLS
Authors: DREES M DENGLER WA ROTH T LABONTE H MAYO J MALSPEIS L GREVER M SAUSVILLE EA FIEBIG HH
Citation: M. Drees et al., FLAVOPIRIDOL (L86-8275) - SELECTIVE ANTITUMOR-ACTIVITY IN-VITRO AND ACTIVITY IN-VIVO FOR PROSTATE CARCINOMA-CELLS, Clinical cancer research, 3(2), 1997, pp. 273-279
IDENTIFICATION OF NOVEL CHEMICAL CLASSES WITH POTENTIAL UTILITY AGAINST AIDS-RELATED LYMPHOMA
Authors: MONKS A HOLLINGSHEAD M SAUSVILLE EA
Citation: A. Monks et al., IDENTIFICATION OF NOVEL CHEMICAL CLASSES WITH POTENTIAL UTILITY AGAINST AIDS-RELATED LYMPHOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 85-85
Risultati: 1-25 | 26-50 | 51-69